UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial

International journal of clinical practice (Esher), 2011-04, Vol.65 (4), p.397-407

2011

Volltextzugriff (PDF)

Liraglutide improves treatment satisfaction in people with Type 2 diabetes compared with sitagliptin, each as an add on to metformin

Diabetic medicine, 2011-03, Vol.28 (3), p.333-337

2011

Volltextzugriff (PDF)

Coordination of DNA Damage Responses via the Smc5/Smc6 Complex

Molecular and Cellular Biology, 2004-01, Vol.24 (2), p.662-674

2004

Volltextzugriff (PDF)

The p53 protein family and radiation sensitivity: Yes or no?

Cancer and metastasis reviews, 2004-08, Vol.23 (3-4), p.237-257

2004

Volltextzugriff (PDF)

Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience

Diabetologia, 2012-06, Vol.55 (6), p.1641-1650

2012

Volltextzugriff (PDF)

The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-α

Oncogene, 1999-10, Vol.18 (42), p.5727-5737

1999

Volltextzugriff (PDF)

Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells

Oncogene, 2001-11, Vol.20 (51), p.7453-7463

2001

Volltextzugriff (PDF)

The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro

Oncogene, 1999-04, Vol.18 (17), p.2690-2702

1999

Volltextzugriff (PDF)

VEGF-mediated cross-talk within the neonatal murine thymus

Blood, 2009-03, Vol.113 (12), p.2723-2731

2009

Volltextzugriff (PDF)

In support of an early polypharmacy approach to the treatment of type 2 diabetes

Diabetes, obesity & metabolism, 2010-11, Vol.12 (11), p.929-940

2010

Volltextzugriff (PDF)

Effects of canagliflozin versus glimepiride on adipokines, inflammatory biomarkers, and chemokines in patients with type 2 diabetes mellitus

Indian heart journal, 2017-11, Vol.69 (S2), p.S93-S94

2017

Volltextzugriff (PDF)

WTp53 induction does not override MTp53 chemoresistance and radioresistance due to gain-of-function in lung cancer cells

Molecular cancer therapeutics, 2008-04, Vol.7 (4), p.980-992

2008

Volltextzugriff (PDF)

Double-Stranded-RNA-Activated Protein Kinase PKR Enhances Transcriptional Activation by Tumor Suppressor p53

Molecular and Cellular Biology, 1999-04, Vol.19 (4), p.2475-2484

1999

Volltextzugriff (PDF)

Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial

The Lancet (British edition), 2010-04, Vol.375 (9724), p.1447-1456

2010

Volltextzugriff (PDF)

Normal p53 Function in Primary Cells Deficient for Siah Genes

Molecular and Cellular Biology, 2002-12, Vol.22 (23), p.8155-8164

2002

Volltextzugriff (PDF)

Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways

The EMBO Journal, 1997-03, Vol.16 (6), p.1291-1304

1997

Volltextzugriff (PDF)

Predictors of Blood Pressure Control in Patients With Diabetes and Hypertension Seen in Primary Care Clinics

American journal of hypertension, 2005-06, Vol.18 (6), p.833-838

2005

Volltextzugriff (PDF)

PDB3 How Different Were They? A Treatment Pattern Analysis of United States Patients With Type 2 Diabetes Mellitus (T2DM) Initiating Injectable Therapy

Value in health, 2012-11, Vol.15 (7), p.A493-A493

2012

Volltextzugriff (PDF)

PDB6 Real-World Comparative Effectiveness Analysis of Patients Initiating Injectable Treatments for Type 2 Diabetes Mellitus (T2DM): Pilot Data From the Initiator Study

Value in health, 2012-11, Vol.15 (7), p.A494-A494

2012

Volltextzugriff (PDF)

Lack of an association between alleles of interleukin-1α and interleukin-1 receptor antagonist genes and Graves' disease in a North American Caucasian population

The journal of clinical endocrinology and metabolism, 1996-12, Vol.81 (12), p.4476-4478

1996

Volltextzugriff (PDF)

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

The Lancet (British edition), 2009-07, Vol.374 (9683), p.39-47

2009

Volltextzugriff (PDF)

Protein kinase inhibitor 2-aminopurine overrides multiple genotoxic stress-induced cellular pathways to promote cell survival

Oncogene, 2003-06, Vol.22 (24), p.3721-3733

2003

Volltextzugriff (PDF)

Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study

Diabetes care, 2017-12, Vol.40 (12), p.1756-1762

2017

Volltextzugriff (PDF)

A comparison between simplified and intensive dose-titration algorithms using AIR inhaled insulin for insulin-naive patients with type 2 diabetes in a randomized noninferiority trial

Diabetes technology & therapeutics, 2009-09, Vol.11 Suppl 2 (s2), p.S53-S-61

2009

Volltextzugriff (PDF)

1 – 25 von 202

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(169)
Mit Volltextzugriff
(135)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(113)
Life Sciences & Biomedicine
(106)
Humans
(79)
Female
(57)
Male
(55)
Animals
(53)
Biological And Medical Sciences
(34)
Aerosols
(27)
Medical Sciences
(26)
Technology
(25)
Environmental Sciences
(24)
Environmental Sciences & Ecology
(24)
Dogs
(22)
Middle Aged
(22)
Public, Environmental & Occupational Health
(22)
Adult
(19)
Endocrinology & Metabolism
(19)
Aged
(16)
Diabetes
(16)
Radiology, Nuclear Medicine & Medical Imaging
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial

Liraglutide improves treatment satisfaction in people with Type 2 diabetes compared with sitagliptin, each as an add on to metformin

Coordination of DNA Damage Responses via the Smc5/Smc6 Complex

The p53 protein family and radiation sensitivity: Yes or no?

Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience

The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-α

Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells

The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro

VEGF-mediated cross-talk within the neonatal murine thymus

In support of an early polypharmacy approach to the treatment of type 2 diabetes

Effects of canagliflozin versus glimepiride on adipokines, inflammatory biomarkers, and chemokines in patients with type 2 diabetes mellitus

WTp53 induction does not override MTp53 chemoresistance and radioresistance due to gain-of-function in lung cancer cells

Double-Stranded-RNA-Activated Protein Kinase PKR Enhances Transcriptional Activation by Tumor Suppressor p53

Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial

Normal p53 Function in Primary Cells Deficient for Siah Genes

Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways

Predictors of Blood Pressure Control in Patients With Diabetes and Hypertension Seen in Primary Care Clinics

PDB3 How Different Were They? A Treatment Pattern Analysis of United States Patients With Type 2 Diabetes Mellitus (T2DM) Initiating Injectable Therapy

PDB6 Real-World Comparative Effectiveness Analysis of Patients Initiating Injectable Treatments for Type 2 Diabetes Mellitus (T2DM): Pilot Data From the Initiator Study

Lack of an association between alleles of interleukin-1α and interleukin-1 receptor antagonist genes and Graves' disease in a North American Caucasian population

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

Protein kinase inhibitor 2-aminopurine overrides multiple genotoxic stress-induced cellular pathways to promote cell survival

Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study

The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study

A comparison between simplified and intensive dose-titration algorithms using AIR inhaled insulin for insulin-naive patients with type 2 diabetes in a randomized noninferiority trial

Suchergebnisse filtern